DSpace About DSpace Software
 

Makerere University Research Repository >
College of Health Sciences >
School of Health Sciences >
Research Articles (Health-Sciences) >

Please use this identifier to cite or link to this item: http://hdl.handle.net/123456789/1475

Title: Proteomics of Marburg and Ebola glycoproteins: Insights into their physiocochemical similarities and irregularities
Authors: Wayengera, Misaki
Kajumbula, Henry
Mulindwa, Kaddu D.
Olobo, Joseph
Byarugaba, Wilson
Keywords: Ebola
Marburg
Glycoproteins
Proteomics
Vaccine research
Infectious diseases
Viral hemorrhagic fevers (VHF)
Issue Date: 2009
Publisher: Academic Journals
Citation: Wayengera, M., Kajumbula, H., Mulindwa, K.D., Olobo, J., Byarugaba, W. (2009). Proteomics of Marburg and Ebola glycoproteins: insights into their physicochemical similarities and irregularities. African Journal of Biotechnology, 8 (17)
Abstract: Ebola (EBO) and Marburg (MBG) form the two major genus of a class of negatively stranded RNA viruses responsible for viral hemorrhagic fevers (VHF) in equatorial Africa called filoviridae. Pathogenesis of VHF is thought to be mediated by the envelope glycoproteins (GP). Although both viruses have been found to be closely related, with a side by side alignment of the gene sequences of the Ebola and Marburg viruses and comparison of protein products showing similarities, there is absence of immunological cross reactivity. The physicochemical properties of the two GP may in part explain this. Using a 676 aa Ebola and 681 aa Marburg GP protein sequences; and the ExPASy Server ProtParam, the physicochemical properties of both proteins were derived and compared. The MBG-GP molecular weight was bigger and more negatively charged than EBO (MW=74481 vs.74464.4 and overall charge=-11 vs.-9). Other constants analyzed respectively: for MBG versus EBO (1) theoretical PI: 5.85 vs. 6.16, (2) extinction coefficient (82110/1.102 vs 100100/1.344 M-1 cm-1 at 280 nm/H2O). The Estimated half life for both glycoproteins was 30 h, although MBG-GP was unstable compared to EBO-GP (The instability index [II]; MBG vs EBO = 42.82 vs. 38.36). These variations must be taken into account in research and development of a common vaccine against both MBG and EBO.
URI: http://www.academicjournals.org/AJB
http://hdl.handle.net/123456789/1475
ISSN: 1684–5315
Appears in Collections:Research Articles (Health-Sciences)

Files in This Item:

File Description SizeFormat
Wayengera-chs-res.pdf84KbAdobe PDFView/Open

All items in DSpace are protected by copyright, with all rights reserved.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2005 MIT and Hewlett-Packard - Feedback